Literature DB >> 27007803

Quantitative Sodium MR Imaging at 7 T: Initial Results and Comparison with Diffusion-weighted Imaging in Patients with Breast Tumors.

Olgica Zaric1, Katja Pinker1, Stefan Zbyn1, Bernhard Strasser1, Simon Robinson1, Lenka Minarikova1, Stephan Gruber1, Alex Farr1, Christian Singer1, Thomas H Helbich1, Siegfried Trattnig1, Wolfgang Bogner1.   

Abstract

Purpose To investigate the clinical feasibility of a quantitative sodium 23 ((23)Na) magnetic resonance (MR) imaging protocol developed for breast tumor assessment and to compare it with 7-T diffusion-weighted imaging (DWI). Materials and Methods Written informed consent in this institutional review board-approved study was obtained from eight healthy volunteers and 17 patients with 20 breast tumors (five benign, 15 malignant). To achieve the best image quality and reproducibility, the (23)Na sequence was optimized and tested on phantoms and healthy volunteers. For in vivo quantification of absolute tissue sodium concentration (TSC), an external phantom was used. Static magnetic field, or B0, and combined transmit and receive radiofrequency field, or B1, maps were acquired, and image quality, measurement reproducibility, and accuracy testing were performed. Bilateral (23)Na and DWI sequences were performed before contrast material-enhanced MR imaging in patients with breast tumors. TSC and apparent diffusion coefficient (ADC) were calculated and correlated for healthy glandular tissue and benign and malignant lesions. Results The (23)Na MR imaging protocol is feasible, with 1.5-mm in-plane resolution and 16-minute imaging time. Good image quality was achieved, with high reproducibility (mean TSC values ± standard deviation for the test, 36 mmol per kilogram of wet weight ± 2 [range, 34-37 mmol/kg]; for the retest, 37 mmol/kg ± 1 [range, 35-39 mmol/kg]; P = .610) and accuracy (r = 0.998, P < .001). TSC values in normal glandular and adipose breast tissue were 35 mmol/kg ± 3 and 18 mmol/kg ± 3, respectively. In malignant lesions (mean size, 31 mm ± 24; range, 6-92 mm), the TSC of 69 mmol/kg ± 10 was, on average, 49% higher than that in benign lesions (mean size, 14 mm ± 12; range, 6-35 mm), with a TSC of 47 mmol/kg ± 8 (P = .002). There were similar ADC differences between benign ([1.78 ± 0.23] × 10(-3) mm(2)/sec) and malignant ([1.03 ± 0.23] × 10(-3) mm(2)/sec) tumors (P = .002). ADC and TSC were inversely correlated (r = -0.881, P < .001). Conclusion Quantitative (23)Na MR imaging is clinically feasible, may provide good differentiation between malignant and benign breast lesions, and demonstrates an inverse correlation with ADC. (©) RSNA, 2016 Online supplemental material is available for this article.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27007803     DOI: 10.1148/radiol.2016151304

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  31 in total

1.  Three-dimensional MR Fingerprinting for Quantitative Breast Imaging.

Authors:  Yong Chen; Ananya Panda; Shivani Pahwa; Jesse I Hamilton; Sara Dastmalchian; Debra F McGivney; Dan Ma; Joshua Batesole; Nicole Seiberlich; Mark A Griswold; Donna Plecha; Vikas Gulani
Journal:  Radiology       Date:  2018-10-30       Impact factor: 11.105

2.  Diagnostic value of electric properties tomography (EPT) for differentiating benign from malignant breast lesions: comparison with standard dynamic contrast-enhanced MRI.

Authors:  Naoko Mori; Keiko Tsuchiya; Deepa Sheth; Shunji Mugikura; Kei Takase; Ulrich Katscher; Hiroyuki Abe
Journal:  Eur Radiol       Date:  2018-09-25       Impact factor: 5.315

Review 3.  Quantitative sodium MR imaging: A review of its evolving role in medicine.

Authors:  Keith R Thulborn
Journal:  Neuroimage       Date:  2016-11-24       Impact factor: 6.556

4.  Potential anticancer effect of prostratin through SIK3 inhibition.

Authors:  Dalal Alotaibi; Suneetha Amara; Terrance L Johnson; Venkataswarup Tiriveedhi
Journal:  Oncol Lett       Date:  2017-12-20       Impact factor: 2.967

5.  A dual-tuned multichannel bilateral RF coil for 1 H/23 Na breast MRI at 7 T.

Authors:  Carlotta Ianniello; Guillaume Madelin; Linda Moy; Ryan Brown
Journal:  Magn Reson Med       Date:  2019-05-31       Impact factor: 4.668

Review 6.  Clinical role of breast MRI now and going forward.

Authors:  D Leithner; G J Wengert; T H Helbich; S Thakur; R E Ochoa-Albiztegui; E A Morris; K Pinker
Journal:  Clin Radiol       Date:  2017-12-09       Impact factor: 2.350

Review 7.  Background, current role, and potential applications of radiogenomics.

Authors:  Katja Pinker; Fuki Shitano; Evis Sala; Richard K Do; Robert J Young; Andreas G Wibmer; Hedvig Hricak; Elizabeth J Sutton; Elizabeth A Morris
Journal:  J Magn Reson Imaging       Date:  2017-11-02       Impact factor: 4.813

8.  In vivo imaging of electrical properties of an animal tumor model with an 8-channel transceiver array at 7 T using electrical properties tomography.

Authors:  Jiaen Liu; Qi Shao; Yicun Wang; Gregor Adriany; John Bischof; Pierre-Francois Van de Moortele; Bin He
Journal:  Magn Reson Med       Date:  2017-01-23       Impact factor: 4.668

Review 9.  The potential of multiparametric MRI of the breast.

Authors:  Katja Pinker; Thomas H Helbich; Elizabeth A Morris
Journal:  Br J Radiol       Date:  2016-11-02       Impact factor: 3.039

Review 10.  [Multiparametric and molecular imaging of breast tumors with MRI and PET/MRI].

Authors:  K Pinker; M A Marino; A Dr Meyer-Baese; T H Helbich
Journal:  Radiologe       Date:  2016-07       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.